Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response
Rufei Lu, Catriona A Wagner, Andrea Fava, et al.
Rheumatology (Oxford, England)
|
March 26, 2024
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network
Philip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, et al.
Arthritis Research & Therapy
|
February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network
Peter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Arthritis Care & Research
|
October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment
Andrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 6, 2020
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
Yemil Atisha-Fregoso, Susan Malkiel, Kristina M Harris, et al.
JCI Insight
|
September 20, 2019
PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21
Alexandra V Bocharnikov, Joshua Keegan, Vanessa S Wacleche, et al.
JCI Insight
|
January 23, 2024
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis
Andrea Fava, Jill Buyon, Laurence Magder, et al.
Lupus Science & Medicine
|
August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network
Kristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
The Journal of Experimental Medicine
|
September 3, 2025
A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis
Paul J Hoover, Chirag Raparia, David J Lieb, et al.
Rheumatology (Oxford, England)
|
February 25, 2022
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership
Philip M Carlucci, Jessica Li, Andrea Fava, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response
Rufei Lu, Catriona A Wagner, Andrea Fava, et al.
Rheumatology (Oxford, England)
|
March 26, 2024
Extrarenal symptoms associate with worse quality of life in patients enrolled in the AMP RA/SLE Lupus Nephritis Network
Philip M Carlucci, Katherine Preisinger, Kristina K Deonaraine, et al.
Arthritis Research & Therapy
|
February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network
Peter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Arthritis Care & Research
|
October 6, 2025
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment
Andrea Fava, Catriona A Wagner, Carla J Guthridge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 6, 2020
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
Yemil Atisha-Fregoso, Susan Malkiel, Kristina M Harris, et al.
JCI Insight
|
September 20, 2019
PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21
Alexandra V Bocharnikov, Joshua Keegan, Vanessa S Wacleche, et al.
JCI Insight
|
January 23, 2024
Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis
Andrea Fava, Jill Buyon, Laurence Magder, et al.
Lupus Science & Medicine
|
August 14, 2021
Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network
Kristina K Deonaraine, Philip M Carlucci, Andrea Fava, et al.
The Journal of Experimental Medicine
|
September 3, 2025
A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis
Paul J Hoover, Chirag Raparia, David J Lieb, et al.
Rheumatology (Oxford, England)
|
February 25, 2022
High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership
Philip M Carlucci, Jessica Li, Andrea Fava, et al.
Page
of 6